0001144204-18-039136.txt : 20180720
0001144204-18-039136.hdr.sgml : 20180720
20180720160135
ACCESSION NUMBER: 0001144204-18-039136
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180719
FILED AS OF DATE: 20180720
DATE AS OF CHANGE: 20180720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Small Derek A
CENTRAL INDEX KEY: 0001613260
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 18962502
MAIL ADDRESS:
STREET 1: C/O ASSEMBLY BIOSCIENCES, INC.
STREET 2: 99 HUDSON STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
BUSINESS PHONE: (212) 554-4388
MAIL ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
tv498888_4.xml
FORM 4
X0306
4
2018-07-19
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001613260
Small Derek A
C/O ASSEMBLY BIOSCIENCES, INC.
11711 N. MERIDIAN STREET, SUITE 310
CARMEL
IN
46032
1
1
0
0
CEO and President
Common Stock
2018-07-19
4
P
0
1200
41.1902
A
668091
D
Common Stock
2018-07-19
4
P
0
1200
41.7692
A
669291
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.98 to $41.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the price range.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.44 to $42.35, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the price range.
/s/ Elizabeth H. Lacy, as Attorney-in-Fact
2018-07-20